Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme

This phase II study aimed at determining the efficacy and safety of irinotecan combined with thalidomide in adults with recurrent glioblastoma multiforme (GBM) not taking enzyme-inducing anticonvulsants (EIACs). Adult patients (⩾18 years) with recurrent GBM with up to three relapses following surger...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Puduvalli, Vinay K., Giglio, Pierre, Groves, Morris D., Hess, Kenneth R., Gilbert, Mark R., Mahankali, Srikanth, Jackson, Edward F., Levin, Victor A., Conrad, Charles A., Hsu, Sigmund H., Colman, Howard, de Groot, John F., Ritterhouse, MeLesa G., Ictech, Sandra E., Alfred Yung, W. K.
Format: Artigo
Jezik:Inglês
Izdano: Duke University Press 2008
Teme:
Clinical Investigations
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2613824/
https://ncbi.nlm.nih.gov/pubmed/18314417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/15228517-2007-060
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki